[Immunologic activity in coronary heart disease and atherosclerosis of the lower extremities]

Katarzyna Mizia-Stec1, Zbigniew Gasior, Barbara Zahorska-Markiewicz

  • 1Katedry i Kliniki Kardiologii, Slaskiej Akademii Medycznej w Katowicach. biboch@slam.katowice.pl

Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|May 12, 2005
PubMed

Insights

Generalized atherosclerosis, particularly peripheral artery disease (PAD), elevates immune activation markers like soluble tumor necrosis factor receptor 1 (sTNFR 1) in coronary heart disease patients. An ECG stress test increases E-selectin levels in these patients.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Biochemistry

Context:

  • Cytokine activation is linked to clinical symptoms in coronary heart disease (CHD) and peripheral artery disease (PAD).
  • Assessing immune activation in CHD patients with generalized atherosclerosis is crucial for understanding disease progression.

Purpose:

  • To investigate the influence of generalized atherosclerosis on immune activation in CHD patients undergoing an ECG stress test.
  • To compare immune marker levels between CHD patients with and without PAD.

Summary:

  • 127 CHD patients (21 with PAD, 106 without) and 20 controls were studied.
  • Serum levels of TNF alpha, sTNFR 1, E-selectin, and sVCAM-1 were measured pre- and post-ECG stress test.
  • Higher TNF alpha and sTNFR 1 levels were observed in CHD patients compared to controls. sTNFR 1 was significantly higher in CHD patients with PAD.

Impact:

  • Generalized atherosclerosis, indicated by PAD presence, correlates with heightened immune activation (higher sTNFR 1) in CHD patients.
  • ECG stress testing significantly increases E-selectin levels in coronary patients, irrespective of PAD.
  • Findings highlight the role of immune system dysregulation in complex cardiovascular disease.

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...